Last reviewed · How we verify
NCT03516500
Trial of Identifying the Lung Intersegmental Plane by Iron Sucrose Injection Staining
NA trial testing Iron Sucrose Injection in Lung Neoplasm in 20 participants. Completed in 21 January 2021.
21 January 2021
Quick facts
| Lead sponsor | Ruijin Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 9 May 2018 |
| Primary completion | 21 January 2021 |
| Estimated completion | 21 January 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Iron Sucrose Injection — full drug profile →
Conditions studied
- Lung Neoplasm — all drugs for Lung Neoplasm →
- Segmentectomy;Intersegmental Plane — all drugs for Segmentectomy;Intersegmental Plane →
Sponsor
Ruijin Hospital
Who can join
Adults 18 to 80, any sex, with Lung Neoplasm or Segmentectomy;Intersegmental Plane. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a protocol to determine the safety and feasibility of using Iron Sucrose Injection to identify the intersegmental plane,not only on the pleural surface but also the parenchyma of the lung.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Robotic lung cancer surgery: from simple to complex, from surgery to clinical study.
Han Y, Zhang Y, Li C, Yang S, et al · · 2020 · cited 3× · PMID 32190353 · DOI 10.21037/jtd.2019.09.79 -
A feasible technique for distinguishing the intersegmental plane by transbronchial injection of iron sucrose.
Li C, Zhang X, Feng X, Han D, et al · · 2023 · PMID 37096093 · DOI 10.1016/j.xjtc.2022.12.007
Verify or expand the search:
- PubMed search for NCT03516500
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Iron Sucrose Injection
Trials testing the same drug.
- NCT06911034 — Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women · Phase 4 · completed
- NCT04155814 — Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects · Phase 1 · completed
- NCT03009578 — Iron Sucrose Versus Ferrous Bis-glycinate for Treatment of Iron Deficiency Anemia · Phase 3 · completed
Other recruiting trials for Lung Neoplasm
Currently open trials in the same condition.
- NCT06780098 — Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell · Phase 2 · recruiting
- NCT06638398 — Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules · NA · active not recruiting
- NCT06158971 — Feasibility Study of the Microwave Ablation System for Lung Tissue Ablation · NA · recruiting
- NCT06254196 — Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates · NA · recruiting
- NCT06419114 — Exploration of Optical Coherence Tomography-Guided Transbronchial Biopsy in Peripheral Pulmonary Lesions · recruiting
Other Ruijin Hospital trials
Trials by the same sponsor.
- NCT07589361 — Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors · not yet recruiting
- NCT07449507 — Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy · NA · not yet recruiting
- NCT07496385 — Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound · NA · not yet recruiting
- NCT07511114 — A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyp · Phase 3 · not yet recruiting
- NCT07514169 — The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03516500 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ruijin Hospital
- Last refreshed: 31 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03516500.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing